This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Understanding current drug scheduling for cannabis The DEA classifies drugs, substances, and certain chemicals used to make drugs into five distinct categories or “schedules.” Abuse rate is a determinate factor in scheduling; Schedule I has the most abuse potential while Schedule V drugs have the least abuse potential.
Nearly 40 years ago, advocates made the case to the DEA’s own judge that cannabis did not meet the definition of a Schedule I controlled substance. Their case is exponentially stronger now. The post NORML Op-Ed: DEA’s Marijuana Hearing Is a Good Opportunity for Advocates To Make the Case for Rescheduling appeared first on NORML.
Cannabis was listed as a Schedule I substance, a category for “drugs with no currently accepted medical use and a high potential for abuse”; this is a stricter classification than even raw opium, which is Schedule II. Now, two-thirds of Americans live in states where medical cannabis is legal.
As a founding Co-Chair of the Congressional Cannabis Caucus, I am pleased to report to you that my legislation to allow VA doctors to fill out state-legal medical marijuana recommendations is scheduled for a committee vote tomorrow. Congressman Earl Blumenauer (D-OR) speaking a NORML Conference.
Update : AB 2355 was scheduled for a hearing in the Assembly Labor And Employment Committee this week, but it was postponed until 4/1/20. The bill now heads to the governor. The bills now heads to the governor. The bill now heads to the governor. CA resident? MD resident? MS resident? New Hampshire. NH resident?
Now, we still have much to do. Build support in the Senate and convince leadership to schedule a vote. Now, we have a public mandate with majorities of Republicans, Democrats, and independent voters all supporting the outright legalization of marijuana. When we raise our voices as one, there is nothing we cannot achieve.
In the first in what are anticipated to be multiple Congressional hearings to address the federal prohibition and criminalization of marijuana, the House Financial Services Committee has scheduled to convene a markup on The Safe Banking Act, HR 1595 on Tuesday, March 26th. With 97.7% of the U.S. Thirty-three states, Washington, D.C.
Sessions , now Washington v. Barr ) sought a declaration that the placement of cannabis in Schedule I of the Controlled Substances Act was unconstitutional because it violates the Due Process Clause of the Fifth Amendment, protections guaranteed by the First Amendment, and the fundamental right to travel.
There are now over 3 million medical cannabis patients across the country; ninety-one percent of Americans now live in states with some form of access to medical cannabis, while sixty-six of American adults are in favor of full legalization.
The hearing, entitled “Marijuana Laws in America: Racial Justice and the Need for Reform,” will discuss alternative policy options — including ending cannabis’ longstanding Schedule I criminal status under federal law.
” Both bills were only assigned to the HVAC, so now it is up to the House Majority to schedule floor time for the whole chamber to cast their votes. This is the culmination of the tremendous work of our movement, but we will not be finished until this becomes the law of the land. We must reform our federal cannabis policy.”
In fact, one can argue that our mission now is more important than ever before. In most states, constituents cannot at this time even schedule a face-to-face meeting with their lawmakers. Even during these uncertain times, NORML’s mission remains the same. ” Download the Resource Guide.
Representatives with the United States Small Business Administration (SBA) recently reaffirmed that state-licensed cannabis businesses are ineligible for financial aid opportunities because marijuana remains classified as a Schedule I Controlled Substance. NORML’s Voting Guide to Legalize Marijuana in Your State.
The bill now heads to the Governor. The bill is scheduled for a hearing in the Judiciary Committee on 6/25/19. Update : SB 34 is scheduled for a hearing in the Assembly Revenue And Taxation Committee on 7/2/19. Update : SB 51 is scheduled for a hearing in the Assembly Business And Professions Committee on 7/9/19.
The bill now heads to the House. The bill now heads to the Senate. Update : SB 2543 scheduled to be heard by the House Committee on Labor & Public Employment on Thursday 3/12/20 at 9am in House conference room 309. The bill now heads to the Senate. The bill now heads to the Senate. AL resident? AZ resident?
Yet, despite the economic and political progress that has been made in states around the country, marijuana is still defined by federal law as a Schedule I substance with no medicinal value and a high potential for abuse. “Now is not the time for Congress to think small,” said NORML Political Director Justin Strekal.
Update : HB 2049 is scheduled for a public hearing in the House Rules Committee at 1pm on 3/9/20. Update : HB 2359 is scheduled for a public hearing in the Senate Commerce Committee at 10am on 3/12/20. Update : HB 528 is scheduled for consideration by the Subcommittee of Judiciary on 3/9/20. The bill now heads to the Senate.
When I can schedule a meeting, it’s now a short phone call. And, that’s why I am asking for your help right now. If you want to see a robust consumer-oriented cannabis marketplace, then we must act now to protect these small businesses. Send a message now! As for right now, this would be a great start.
Update : LD 1621 is scheduled for a public hearing in the State House on 1/27/20 at 10am. Update : HB 83 is scheduled for a public hearing in the House Judiciary Committee on 1/28/20 at 1pm. Update : SB 179 is scheduled for a public hearing in the Senate Judicial Proceedings Committee on 1/29/20 at 1pm. ME resident? MD resident?
Update : SB 305 is scheduled for a hearing in the Senate Committee on Health on 4/10/19. Update : HB 7371 is scheduled for consideration by the Office of Legislative Research and Office of Fiscal Analysis on 4/9/19 at 5pm. Update : SB 24 is scheduled for a hearing in the Senate Health and Social Services Committee on 4/10/19.
On Thursday, April 25, members of the Texas House of Representatives are scheduled to consider a marijuana decriminalization bill. Click here to send a message to your Texas state representatives now in support of decriminalization, and urge them to co-author HB 63.
Update : AB 286 is scheduled for a hearing in the Assembly Business And Professions Committee on 4/23/19. Update : SB 34 is scheduled for a hearing in the Senate Appropriations Committee on 4/22/19. Update : Ab 1465 is scheduled for a hearing in the Assembly Business And Professions Committee on 4/23/19. California. CA resident?
North Dakota’s first medical cannabis dispensary opened its doors last week in Fargo; and registered out-of-state medical cannabis patients will now be able to access their medicine while visiting Hawaii. Update : HB 1518 is scheduled for a hearing in the Senate Judiciary Committee on 3/11/2019. AR resident? FL resident?
” NORML has submitted written comments to the FDA ahead of Friday’s scheduled hearing on the regulation of CBD-infused products. . “With states rapidly legalizing the distribution of these products, consumers require certainty and consistency when it comes what they ingest.”
Send a message to your lawmakers in support of ending prohibition and criminalization now! The MORE Act was introduced by the Committee’s Chairman, Jerry Nadler of New York and it is expected to be positively received by Committee members.
Several bills have been introduced in the state legislature, ranging from legalization to expungement, and the fight for freedom has never been more widely supported than now. Send a general letter in support of sensible marijuana reform in New Jersey NOW. In New Jersey, there has been a great deal of progress in the last few years.
The bill is scheduled to be considered by the Judiciary Committee again on 5/8/19. Update : HB 19-1230 was approved by the Senate on 5/1/19, and now heads back to the House for concurrence on Senate amendments. Update : HB 19-1234 was approved by the Senate on 5/1/19, and will now head to the Governor’s desk. AL resident?
NORML has submitted written comments to the US Food and Drug Administration ahead of the agency’s scheduled hearing on the regulation CBD-infused products. ” The FDA is accepting written comments from the public through July 2, 2019.
Send a message to your representatives in support of the MORE Act now. Update : HB 1089 is scheduled for a public hearing in the House Business Affairs & Labor Committee at 1:30 on 2/19/2020 in Room LSB-A. Update : HB 583 is scheduled to be heard by the House Health Committee on 1/28/20 8:35am in House conference room 329.
It now awaits consideration by the U.S. New Jersey tabled a scheduled vote to pass adult-use marijuana legalization after falling just a few votes short of the threshold needed to pass. Legalization legislation now awaits another floor date while advocates in New Jersey gain the necessary support to pass it. CA resident?
.” “This will certainly not be the last hearing of this Congress to have a high-minded conversation about marijuana and we expect a full hearing on prohibition to be scheduled in the months to come.” Specifically, a 2019 report estimates that over 211,000 Americans are now working full-time in the cannabis industry.
Update : SB 8 is scheduled for a public hearing in the Senate Judiciary Committee at 1:30pm on 3/4/20. Update : HB 528 is scheduled for consideration by the Subcommittee of Judiciary on 3/5/20 and 3/6/20. The bill now heads to the Senate. Update : LD 1621 is scheduled for a public hearing in the State House on 3/2/20 at 10am.
Update : A substitute version of SB 236 that would create a commission to study the use of medical CBD is scheduled for a hearing and vote in the House Committee on Health on 5/28/19. Update : SB 34 was approved by the Senate on 5/20/19, and now heads to the Assembly. The bill now heads to the governor. AL resident? California.
Additionally, marijuana is listed as a Schedule I hallucinogenic substance, making it subject to legal limitations and control. New Bills on the Table Now, two new bills have been proposed that may bring some changes for cannabis users in Texas. What Will Happen Now?
Update : SB 19-013 is scheduled for a hearing in the House Health & Insurance Committee for 3/6/2019 at 1:30pm, room 0107. Update : HB 19-1028 is scheduled for a hearing in the Senate Health & Human Services Committee at 1:30pm on 3/14/2019, Room LSB-B. GA resident? HI resident? IN resident? MN resident? New Hampshire.
Another hearing is scheduled for Thursday, where the Veterans Affairs Committee will discuss various bills that are pending regarding medical cannabis programs and veterans access. Update : SB 305 is scheduled for a hearing in the Assembly Health Committee on 7/2/19. CA resident? DE resident? NH resident? North Carolina.
Update : Both bills are scheduled for a public hearing in the Joint Committee on Environment on 3/1. The bill is scheduled to be considered by the full committee on 2/25. Update : SB 864 is scheduled for a public hearing in the Senate on 2/26. Update : SB 864 is scheduled for a public hearing in the Senate on 2/26.
And cannabis is still in Schedule One of the Controlled Substances Act, making it unavailable at the federal level for therapeutic use. It’s urgent that we get it out of Schedule One. I think one major motivation is that a lot of these people have become very disillusioned with the practice of medicine as it now is.
The bill will now be transmitted to the governor. Update : SB 34 is scheduled for a hearing in the Senate Governance and Finance Committee on 3/20 at 9:30am in room 112. The bill will now be transmitted to the governor. Update : SB 167 is scheduled for a hearing in the House Agriculture Committee on 3/21 at 3:00pm in room 137.
Department of Health and Human Services released an official 252-page document outlining their reasoning for rescheduling cannabis to Schedule III under the Controlled Substances Act (CSA). Its current status as Schedule I considers it a dangerous and addictive substance with no medical potential.
Update : HB 96 is scheduled for a hearing in the House Committee on Judiciary on 5/1/19 at 1:30pm. Update : SB 893 was approved by the Senate on 4/2519, and will now be transmitted to the House. Update : SB 1020 was approved by the Senate on 4/24/19, and now will be transmitted to the House. AL resident? CT resident?
SEND A MESSAGE NOW. Drug Enforcement Administration and Congress still erroneously classify marijuana as a Schedule 1 drug, ignoring the fact that 33 states, including my home state of Hawai‘i, have already accepted the medical use of marijuana under state law. Don Young (R-AK) as a cosponsor of the bill. However, the U.S.
formally reclassified cannabis, removing the substance from Schedule IV (although cannabis and its derivatives still remain in Schedule I). Removes Marijuana from Schedule IV. Until today’s historic vote, cannabis was listed as a Schedule IV substance under the 1961 U.N. As Ethan Glick , a U.S. Whether the U.S.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content